Innovative RNA Platform Ethris utilizes proprietary messenger RNA technology to develop transcript therapies, presenting opportunities to partner with biopharmaceutical companies seeking advanced RNA-based treatments and vaccine solutions.
Strategic Collaborations Recent partnerships with Evonik, Thermo Fisher Scientific, and Lonza highlight Ethris's position as a collaborator for advanced delivery systems and manufacturing, indicating potential upsell opportunities in customizable RNA and nanoparticle solutions.
Funding and Growth Potential With significant grants and investments, including an €11.4 million EU4Health grant, Ethris is expanding its development pipeline, creating opportunities to offer supportive services, technologies, or co-development partnerships.
Focus on Respiratory Vaccines Development of spray-dried mRNA vaccines for respiratory diseases opens avenues for engaging with respiratory health providers, vaccine manufacturers, and biotech firms interested in nasal and inhalable vaccine platforms.
Emerging Market Presence Operating in the clinical-stage biotech sector with a focus on innovative gene-to-therapy solutions, Ethris's growth trajectory and recent technological advances make it a promising target for supply chain, manufacturing, and research service providers.
$250M$500M
$1M$10M
$1B$10B
$250M$500M
$1M$10M
$10B
$1M$10M
$1M$10MEthris uses 8 technology products and services including Twemoji, JSON-LD, React, and more. Explore Ethris's tech stack below.
| Ethris Email Formats | Percentage |
| Last@ethris.com | 50% |
| Last@ethris.com | 50% |
Biotechnology ResearchBavaria, Germany51-200 Employees
Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technology. Developed in-house, our integrated platform enables the discovery, design and development of transcript therapies that restore missing functions in patients’ cells and tissues. We will advance transcript therapies to transform the treatment of disease independently and with our partners.
Company Overview
Media & News
Funding & FinancialsEthris has raised a total of $11M of funding over 9 rounds. Their latest funding round was raised on May 06, 2025 in the amount of $11M.
Ethris's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsEthris has raised a total of $11M of funding over 9 rounds. Their latest funding round was raised on May 06, 2025 in the amount of $11M.
Ethris's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com